Jyong Biotech Ltd. (Revived IPO) MENS 深 沪
已收盘 08-01 16:00:00 美东时间
19.12
+0.060
+0.31%
华盛通- 最 高19.88
- 今 开19.06
- 成交量 10.74万股
- 最 低 16.97
- 昨 收 19.06
- 总市值 14.54亿
- 52周最高 22.63
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 6.0101
- 委 比 54.08%
- 总股本 7602.77万
- 历史最高 22.63
- 量 比 0.85
- 振 幅 15.27%
- 历史最低 6.0101
- 每 手 1
- 风险率 2.89%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股周涨跌榜 | 上市首周受热捧，Figma周涨近270%；乳腺癌药物实验效果积极，CELC周涨近190%
上市首周受热捧，Figma周涨近270%；乳腺癌药物实验效果积极，CELC周涨近190%；FDA人事变动或缓解监管压力，SRPT周涨超33%>>
今天 10:39
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Soligenix (NASDAQ:SNGX) shares rose 192.0% to $3.65 during Thursday's ...
08-01 01:08
美股周涨跌榜 | 本周飙升568%！Abivax S.A.新药III期研究成功；CRO股Medpace周涨超43%
本周飙升568%！生物技术公司Abivax S.A.溃疡性结肠炎口服药物III期研究成功；CRO股Medpace周涨超43%，Q2营收和EBITDA均超预期>>
07-26 10:23
Jyong Biotech Ltd. Rings Nasdaq Bell and Participates at the BIO 2025 International Convention
Jyong Biotech Ltd., a Taiwan-based biotech company specializing in plant-derived drugs for urinary system diseases, completed its Nasdaq IPO and participated in BIO 2025, showcasing its flagship product MCS-2 targeting the BPH market. With global aging and rising obesity driving demand, the BPH market is projected to grow from $4.1B in 2020 to $9.8B by 2026. The company aims to leverage its plant-based drug innovation and global partnerships to e...
07-22 14:40
Why Thumzup Media Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Shares of Thumzup Media Corporation (NASDAQ:TZUP) rose sharply in today's pre-m...
07-01 17:23
Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining more ...
06-18 20:35
美股牛股 | VERV暴涨逾81%！获礼来13亿收购；APPS绩后涨近57%
VERV暴涨逾81%！获礼来13亿美元溢价130%收购；APPS涨近57%，公司财报表现超预期>>
06-18 18:22
Jyong Biotech Ltd. Announces Pricing of $20 Million Initial Public Offering
Jyong Biotech Ltd., a biotechnology company based in Taiwan specializing in plant-derived drugs for urinary system diseases, has announced the pricing of its initial public offering (IPO) of 2,666,667 ordinary shares at $7.50 per share, expected to raise approximately $20 million. The shares will list on the Nasdaq Global Market under the ticker "MENS" starting June 17, 2025, with the offering closing on June 18, 2025. The proceeds will fund clin...
06-17 03:38
一周IPO | 霸王茶姬登陆美股！映恩生物首日大涨116%，创年内新股涨幅之冠
霸王茶姬成为美股“新茶饮第一股”；映恩生物首挂飙升116%，创年内新股涨幅之冠；超巨头IPO临近！万亿市值宁德时代获批在港上市>>
04-18 17:36
美股机会日报丨零售数据超预期！三大期指盘前走低；对冲基金出手1亿美元“狙击”特朗普
零售数据超预期！三大期指盘前走低；黄金涨破3300美元关口，金矿股盘前再度冲高；对冲基金“狙击”特朗普，出手1亿美元做空DJT>>
04-16 20:35
